"At New Jersey Cardiology Associates (NJCA), we focus on delivering the highest standard of personalized cardiac care. The physicians and staff at NJCA are dedicated to caring for you and your heart through prevention, detection, and treatment of cardiovascular disease. We offer a full range of in-office services, with expanded hours, state-of-the-art imaging facilities, and complete hospital services. Our physicians are board certified in cardiology, interventional cardiology, electrophysiology, and/or cardiac devices and include a dedicated congestive heart failure clinic. We strive to provide our patients with the finest cardiac care through our medical expertise, compassion, and commitment to excellence."

During the past decade, New Jersey Cardiology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Jersey Cardiology Associates" #1 collaborator was "Milton S. Hershey Medical Center" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New Jersey Cardiology Associates" are "Heart Failure" (4 trials), "Bradycardia" (1 trials), "Cardiovascular Diseases" (1 trials), "Heart Disease" (1 trials) and "Heart Diseases" (1 trials). Many other conditions were trialed in "New Jersey Cardiology Associates" in a lesser frequency.

Most popular intervention types in "New Jersey Cardiology Associates" are "Device" (4 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACUITY Spiral Left Ventricular Lead" (1 trials), "COGNIS CRT-D" (1 trials), "Cardiac Rhythm Management device" (1 trials), "Implantation of a QuickFlex® μ Model 1258T LV Lead" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Jersey Cardiology Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "New Jersey Cardiology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in New Jersey Cardiology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Jersey Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".